全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

谢晶日教授从肝脾论治肝纤维化经验
Experience of Professor Xie Jingri in Treating Liver Fibrosis from the Perspective of Liver and Spleen

DOI: 10.12677/acm.2024.1472164, PP. 1435-1440

Keywords: 肝纤维化,辨证论治,谢晶日,名医经验
Hepatic Fibrosis
, Syndrome Differentiation and Treatment, Xie Jingri, Experience of Famous Doctors

Full-Text   Cite this paper   Add to My Lib

Abstract:

谢晶日教授对治疗肝纤维化有着丰富的经验,认为病机属本虚标实,湿、热、痰、瘀、毒为其主要的病理因素,病机的关键是肝失疏泄,日久成瘀。临证时以治血为主线,并将其贯穿始终,并总以补肾健脾、疏肝活血为基本治法,临床上疗效显著,并附验案一则用以参考。
Professor Xie Jingri has rich experience in the treatment of hepatic fibrosis, and believes that the pathogenesis is deficiency of the essence and excess of the substance, with dampness, heat, phlegm, blood stasis and toxin as the main pathological factors. The key of the pathogenesis is the loss of liver discharge, which becomes blood stasis over time. In clinical practice, blood treatment is the main line, which runs through the whole process, and tonifying the kidney and spleen, soothing the liver and activating blood circulation are the basic treatment methods, with remarkable clinical effect. An experimental case is attached for reference.

References

[1]  翁飞鸿, 周一平, 伊思敏, 等. 肝纤维化的病理学发生机制及诊疗研究进展[J]. 天津医科大学学报, 2023, 29(5): 559-563.
[2]  陆伦根, 尤红, 谢渭芬, 等. 肝纤维化诊断及治疗共识(2019年)[J]. 临床肝胆病杂志, 2019, 35(10): 2163-2172.
[3]  苏静, 胡以平. 肝纤维化发生及逆转途径的研究进展[J]. 癌变?畸变?突变, 2022, 34(3): 242-246.
[4]  中国中西医结合学会肝病专业委员会. 肝纤维化中西医结合诊疗指南(2019年版) [J]. 中华肝脏病杂志, 2019, 27(7): 494-504.
[5]  徐列明. 《肝纤维化中西医结合诊疗指南(2019年版)》解读[J]. 上海中医药杂志, 2020, 54(3): 29-31+52.
[6]  徐列明, 刘平, 沈锡中, 等. 肝纤维化中西医结合诊疗指南(2019年版) [J]. 中国中西医结合杂志, 2019, 39(11): 1286-1295.
[7]  张良登, 孙晓红, 魏玮, 等. 肝纤维化中医理论源流[J]. 世界中西医结合杂志, 2014, 9(3): 300-304.
[8]  刘洋. 谢晶日教授治疗肝纤维化辨证用药规律研究[D]. [硕士学位论文]. 哈尔滨: 黑龙江中医药大学, 2012.
[9]  张旭, 刘朝霞, 赵世聪, 等. 谢晶日辨治非酒精性脂肪肝经验[J]. 吉林中医药, 2020, 40(8): 1021-1024.
[10]  王华林. 谢晶日教授治疗肝纤维化用药规律及经验总结[D]. [硕士学位论文]. 哈尔滨: 黑龙江中医药大学, 2022.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133